Clinically, elevated expression levels of active caspase-1 and IL-1β can be found in AD patients (Blum-Degen et al., 1995; Heneka et al., 2013), which is related to the activation of the NLRP3 inflammasome. Here, IL1B is linked to Alzheimer disease.